A detailed history of Mrp Capital Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mrp Capital Investments, LLC holds 9,358 shares of BMY stock, worth $560,263. This represents 0.48% of its overall portfolio holdings.

Number of Shares
9,358
Previous 58 16034.48%
Holding current value
$560,263
Previous $3 Million 17537.09%
% of portfolio
0.48%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$51.92 - $59.94 $482,856 - $557,442
9,300 Added 16034.48%
9,358 $529 Million
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $2,300 - $3,001
58 New
58 $3 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $12,805 - $14,218
-201 Reduced 77.61%
58 $3.71 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $13,207 - $14,980
201 Added 346.55%
259 $18 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $3,971 - $4,703
58 New
58 $4.17 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $127B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mrp Capital Investments, LLC Portfolio

Follow Mrp Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mrp Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mrp Capital Investments, LLC with notifications on news.